Gastrointestinal Manifestations of COVID-19: Latest Data on Symptoms, Stool Testing, and Clinical Outcomes

Content Type: presentation

Presenter: Brennan M. Spiegel, MD, MSHS, FACG; Paul Y. Kwo, MD, FACG; Millie D. Long, MD, MPH, FACG; Jordan E. Axelrad, MD, MPH; Mark B. Pochapin, MD, FACG; David A. Greenwald, MD, FACG

Presenter Disclosure: According to ACCME guidance, because there are no current preventive or specific treatments for coronavirus infection, there are no relevant conflicts of interest for Dr. Pochapin, Dr. Greenwald, Dr. Spiegel, and Dr. Axelrad. Dr. Kwo- Advisory Board: Gilead; Dr. Long Consultant: AbbVie, Janssen, Pfizer, Prometheus, Salix, Takeda, Target PharmaSolutions, UCB, Valeant Grant Support: Pfizer, Takeda

Event: ACG Virtual Grand Rounds

Release Date: 5/22/2020

Expiration Date: 5/22/2023

Objective: Review the pathogenesis of COVID-19 on the digestive tract, discuss data and case studies on gastrointestinal manifestations of COVID-19, evaluate the potential benefits of stool testing in the diagnosis of COVID-19, and analyze the latest epidemiological data on COVID-19 and the GI tract.